Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.

The dollar’s worst start to a year on record, Bristol Myers plans to develop new cancer drug, Apple’s WWDC is coming, and ...